Literature DB >> 1749228

Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.

J L Dhondt1, J P Farriaux, J C Sailly, T Lebrun.   

Abstract

A comparison between the cost of identification and care of patients with phenylketonuria (PKU) and congenital hypothyroidism (CH) and the expenditure for the care of untreated retarded patients has been established on the basis of the activity of the Nord-Pas-de-Calais regional screening centre and of interviews with patients' families. The analysis yields a benefit-cost ratio of 6.6 for PKU and 13.8 for CH prophylaxis. However, cost-benefit varies depending on the economic partner, i.e. the patient's family, Social Security or Administration.

Entities:  

Mesh：

Year:  1991        PMID： 1749228     DOI： 10.1007/bf01797933

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  3 in total

1.  A cost-benefit analysis of the Quebec Network of Genetic Medicine.

Authors:  D L Dagenais; L Courville; M G Dagenais
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

2.  [Cost/benefit study of the neonatal detection of phenylketonuria and hypothyroidism].

Authors:  J L Dhondt; J P Farriaux; T Lebrun; J C Sailly
Journal:  Pediatrie       Date:  1988

3.  [Evaluation of the detection of phenylketonuria and hypothyroidism at the Lille Regional Center].

Authors:  J L Dhondt; J P Farriaux; M Raux; E Paux; A M Bouchery; J Debersée
Journal:  Arch Fr Pediatr       Date:  1987-11
  3 in total
  8 in total

1.  Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Authors:  J Lord; M J Thomason; P Littlejohns; R A Chalmers; M D Bain; G M Addison; A H Wilcox; C A Seymour
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-05-01

3.  Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London.

Authors:  A Streetly; C Grant; G Bickler; P Eldridge; S Bird; W Griffiths
Journal:  BMJ       Date:  1994-08-06

4.  Long-Term Neurological Outcomes of Adult Patients with Phenylketonuria before and after Newborn Screening in Japan.

Authors:  Kenji Yamada; Seiji Yamaguchi; Kazunori Yokoyama; Kikumaro Aoki; Takeshi Taketani
Journal:  Int J Neonatal Screen       Date:  2021-04-14

Review 5.  Congenital hypothyroidism.

Authors:  Pankaj Agrawal; Rajeev Philip; Sanjay Saran; Manish Gutch; Mohd Sayed Razi; Puspalata Agroiya; Keshavkumar Gupta
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

6.  Lifetime Cost Effectiveness of Phenylketonuria Screening National Program in Iran.

Authors:  Alireza Heidari; Mohammad Arab; Behzad Damari
Journal:  Iran J Public Health       Date:  2021-10       Impact factor: 1.429

7.  Challenges of Implementation of the National Phenylketonuria Screening Program in Iran: A Qualitative Study.

Authors:  Alireza Heidari; Mohammad Arab; Koorosh Etemad; Behzad Damari; Mohammad Javad Kabir
Journal:  Electron Physician       Date:  2016-10-25

8.  Implementing the six sigma model on the treatment of congenital hypothyroidism: An analytical hierarchy process.

Authors:  Hosein Ebrahimipour; Salman Shojaei; Ameneh Esfandyari; Salah Eddin Karimi; Ali Vafaee Najar; Habibollah Esmaily
Journal:  Med J Islam Repub Iran       Date:  2021-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.